CD14 and melanoma: Although the detailed characteristics are not known, microvesicles isolated from plasma of advanced melanoma patients, but not from healthy donors were shown to address CD14+ monocytes, resulting in CD14+ suppressed T-cell functions (possible with downregulation of HLA-DR) [49].